Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2,4,6-trimethoxyphenyl-3-pyrrolidine Propyl Ketone
2. Blufomedil
3. Bufedil
4. Buflo 1a Pharma
5. Buflo Abz
6. Buflo-pos
7. Buflo-puren
8. Buflohexal
9. Buflomedil
10. Buflomedil Heumann
11. Buflomedil Lindo
12. Buflomedil Pyridoxal Phosphate
13. Buflomedil Stada
14. Buflomedil Von Ct
15. Buflomedil-ratiopharm
16. Bufomedil
17. Fonzylane
18. Ll 1656
19. Lofton
20. Loftyl
21. Sinoxis
1. Buflomedil Hcl
2. 35543-24-9
3. Fonzylane
4. Loftyl
5. Buflomedil (hydrochloride)
6. 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone Hydrochloride
7. Mls000028735
8. 3j944afs8s
9. Bufedil
10. Nsc-759291
11. Irrodan
12. Smr000058803
13. Lofton
14. 4-(pyrrolidin-1-yl)-1-(2,4,6-trimethoxyphenyl)butan-1-one Hydrochloride
15. Dsstox_cid_26977
16. Dsstox_rid_82032
17. Dsstox_gsid_46977
18. Buflocit
19. Buflan
20. Irrodan R
21. Buflomedil Hydrochloride [jan]
22. Sr-01000721839
23. Ncgc00016831-01
24. Cas-35543-24-9
25. Ll 1656
26. Unii-3j944afs8s
27. 4-pyrrolidin-1-yl-1-(2,4,6-trimethoxyphenyl)butan-1-one;hydrochloride
28. Prestwick_782
29. Einecs 252-611-9
30. Mfcd00078965
31. Opera_id_262
32. Bucladesine (calcium Salt)
33. A-48257
34. Buflomedil Hydrochloride,(s)
35. Mls001148174
36. Mls001401458
37. Mls002222262
38. Mls006010627
39. Schembl211907
40. Chembl1715107
41. Dtxsid6046977
42. Buflomedil For Peak Identification
43. Hms1569e14
44. Pharmakon1600-01505992
45. Bcp13305
46. Hy-b0484
47. Tox21_110636
48. Tox21_301435
49. 4-(1-pyrrolidyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone Hydrochloride
50. Buflomedil Hydrochloride [mi]
51. Nsc759291
52. S2607
53. Akos015962015
54. Chlorhydrate De (trimethoxy-2-4-6) Phenyl-(pyrrolidine-3) Propylacetone
55. Tox21_110636_1
56. Ab03021
57. Ccg-100878
58. Ds-9078
59. Nc00128
60. Nsc 759291
61. Buflomedil Hydrochloride [mart.]
62. Chlorhydrate De (trimethoxy-2-4-6) Phenyl-(pyrrolidine-3) Propylacetone [french]
63. Buflomedil Hydrochloride [who-dd]
64. Ncgc00016831-06
65. Ncgc00180961-01
66. Ncgc00256242-01
67. Ac-15509
68. B3647
69. Buflomedil Hydrochloride, Analytical Standard
70. Ft-0623281
71. Sw196920-4
72. Buflomedil Hydrochloride [ep Monograph]
73. 543b249
74. Q-200766
75. Sr-01000721839-4
76. Sr-01000721839-5
77. Q27257293
78. Buflomedil Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
79. Buflomedil Hydrochloride, European Pharmacopoeia (ep) Reference Standard
80. 1-butanone, 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-, Hydrochloride
81. Buflomedil For Peak Identification, European Pharmacopoeia (ep) Reference Standard
Molecular Weight | 343.8 g/mol |
---|---|
Molecular Formula | C17H26ClNO4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 8 |
Exact Mass | 343.1550360 g/mol |
Monoisotopic Mass | 343.1550360 g/mol |
Topological Polar Surface Area | 48 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 330 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Buflomedil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Buflomedil, including repackagers and relabelers. The FDA regulates Buflomedil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Buflomedil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Buflomedil supplier is an individual or a company that provides Buflomedil active pharmaceutical ingredient (API) or Buflomedil finished formulations upon request. The Buflomedil suppliers may include Buflomedil API manufacturers, exporters, distributors and traders.
click here to find a list of Buflomedil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Buflomedil DMF (Drug Master File) is a document detailing the whole manufacturing process of Buflomedil active pharmaceutical ingredient (API) in detail. Different forms of Buflomedil DMFs exist exist since differing nations have different regulations, such as Buflomedil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Buflomedil DMF submitted to regulatory agencies in the US is known as a USDMF. Buflomedil USDMF includes data on Buflomedil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Buflomedil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Buflomedil suppliers with USDMF on PharmaCompass.
A Buflomedil CEP of the European Pharmacopoeia monograph is often referred to as a Buflomedil Certificate of Suitability (COS). The purpose of a Buflomedil CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Buflomedil EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Buflomedil to their clients by showing that a Buflomedil CEP has been issued for it. The manufacturer submits a Buflomedil CEP (COS) as part of the market authorization procedure, and it takes on the role of a Buflomedil CEP holder for the record. Additionally, the data presented in the Buflomedil CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Buflomedil DMF.
A Buflomedil CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Buflomedil CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Buflomedil suppliers with CEP (COS) on PharmaCompass.
Buflomedil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Buflomedil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Buflomedil GMP manufacturer or Buflomedil GMP API supplier for your needs.
A Buflomedil CoA (Certificate of Analysis) is a formal document that attests to Buflomedil's compliance with Buflomedil specifications and serves as a tool for batch-level quality control.
Buflomedil CoA mostly includes findings from lab analyses of a specific batch. For each Buflomedil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Buflomedil may be tested according to a variety of international standards, such as European Pharmacopoeia (Buflomedil EP), Buflomedil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Buflomedil USP).
LOOKING FOR A SUPPLIER?